Plasma Therapy

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.

Convalescent plasma therapy, which uses the blood of recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Veteran actor Soumitra Chatterjee is currently in intensive care due to complications linked to Covid-19. The octogenarian was admitted to the Belle Vue hospital in Kolkata on Tuesday, after testing positive a day before. His daughter said Mr Chatterjee is suffering from Covid encephalopathy and is disoriented and restless.

Union Health Minister Dr Harsh Vardhan on Sunday cautioned against "routine use" of plasma therapy and anti-viral drug Remdesivir to treat COVID-19 patients, stating that these are "investigational therapies" and should be adopted "rationally".

Delhi Deputy Chief Minister Manish Sisodia, who was admitted to hospital on Wednesday after testing positive for COVID-19, underwent plasma therapy at a private hospital in the city today to help him fight the infectious virus

Convalescent plasma therapy has not been recommended by the Ministry of Health as a mainstay of COVID-19 therapy and there is no proposal under consideration to set up plasma banks, Rajya Sabha was informed.

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

The India Council of Medical Research, in a study, said plasma therapy for COVID-19 neither reduces the death risk nor does it slow down the progression of the disease from mild to severe stage.

The Convalescent Plasma (CP) therapy didn't help in reducing death due to the coronavirus, the India Council of Medical Research (ICMR) revealed in a study.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

The World Health Organization on Monday was cautious about endorsing the use of recovered COVID-19 patients' plasma to treat those who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.

Convalescent plasma therapy, which uses the blood of recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Veteran actor Soumitra Chatterjee is currently in intensive care due to complications linked to Covid-19. The octogenarian was admitted to the Belle Vue hospital in Kolkata on Tuesday, after testing positive a day before. His daughter said Mr Chatterjee is suffering from Covid encephalopathy and is disoriented and restless.

Union Health Minister Dr Harsh Vardhan on Sunday cautioned against "routine use" of plasma therapy and anti-viral drug Remdesivir to treat COVID-19 patients, stating that these are "investigational therapies" and should be adopted "rationally".

Delhi Deputy Chief Minister Manish Sisodia, who was admitted to hospital on Wednesday after testing positive for COVID-19, underwent plasma therapy at a private hospital in the city today to help him fight the infectious virus

Convalescent plasma therapy has not been recommended by the Ministry of Health as a mainstay of COVID-19 therapy and there is no proposal under consideration to set up plasma banks, Rajya Sabha was informed.

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

The India Council of Medical Research, in a study, said plasma therapy for COVID-19 neither reduces the death risk nor does it slow down the progression of the disease from mild to severe stage.

The Convalescent Plasma (CP) therapy didn't help in reducing death due to the coronavirus, the India Council of Medical Research (ICMR) revealed in a study.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

The World Health Organization on Monday was cautious about endorsing the use of recovered COVID-19 patients' plasma to treat those who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.